INDP Indaptus Therapeutics
WatchlistIndaptus Therapeutics News
Indaptus Therapeutics: Q3 2023 Earnings Report
Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Indaptus Therapeutics | 8-K: Current report
Indaptus Therapeutics | 8-K: Current report
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Anderson Glen R.
Indaptus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Glen R. Anderson(14.17%)
Indaptus Therapeutics | 10-Q: Q2 2023 Earnings Report
Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Indaptus Therapeutics | 8-K: Current report
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Waltzman Roger J.
Indaptus Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Waltzman Roger J.
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Karah Hila
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hayes William B
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gilbert Mark John
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pomerantz Roger
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MADDALUNA ANTHONY J
Indaptus Therapeutics | 8-K: Current report
Indaptus Therapeutics | 10-Q: Q1 2023 Earnings Report
Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
Indaptus Therapeutics | DEFA14A: Others